Cargando…

Clinical Characteristics of Coronary Drug-Eluting Stent Fracture: Insights from a Two-Center DES Registry

Stent fracture (SF) has been implicated as a risk factor for in-stent restenosis, but its incidence and clinical characteristics are not well established. Therefore we investigated the conditions associated with stent fracture and its clinical presentation and outcome. Between 2004 and 2007, consecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Kyung Woo, Park, Jin Joo, Chae, In-Ho, Seo, Jae-Bin, Yang, Han-Mo, Lee, Hae-Young, Kang, Hyun-Jae, Cho, Young-Seok, Yeon, Tae-Jin, Chung, Woo-Young, Koo, Bon-Kwon, Choi, Dong-Ju, Oh, Byung-Hee, Park, Young-Bae, Kim, Hyo-Soo
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012850/ https://www.ncbi.nlm.nih.gov/pubmed/21218030 http://dx.doi.org/10.3346/jkms.2011.26.1.53

Ejemplares similares

Safety and Efficacy of Second-Generation Drug-Eluting Stents in Real-World Practice: Insights from the Multicenter Grand-DES Registry
por: Ki, You-Jeong, et al.
Publicado: (2020)

Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry
por: Shin, Eun-Seok, et al.
Publicado: (2023)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
por: Zheng, Chengbin, et al.
Publicado: (2019)

Comparison of Angiographic Outcomes of Side Branch Ostium at Bifurcation Coronary Lesion between Two-stent and One-stent Techniques
por: Seo, Jae-Bin, et al.
Publicado: (2015)

Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
por: Kim, Soo‐Hyun, et al.
Publicado: (2019)

Clinical and Angiographic Outcomes of the First Korean-made Sirolimus-Eluting Coronary Stent with Abluminal Bioresorbable Polymer
por: Yang, Hyoung-Mo, et al.
Publicado: (2017)

Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease
por: Lee, Seung-Pyo, et al.
Publicado: (2010)

Analysis of Potential Cost-Savings After Introduction of Drug-Eluting Balloon Angioplasty for In-Stent Restenosis or Small Vessel Disease
por: Park, Kyungil, et al.
Publicado: (2011)

Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial
por: Chae, In-Ho, et al.
Publicado: (2017)

Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymer
por: Seo, Kyoung-Woo, et al.
Publicado: (2021)

Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions
por: Choi, Wonsuk, et al.
Publicado: (2019)

Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea
por: Lee, Joo Myung, et al.
Publicado: (2013)

Two Cases of Immediate Stent Fracture after Zotarolimus-Eluting Stent Implantation
por: Lee, Pil Hyung, et al.
Publicado: (2015)

Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial
por: Lee, Joo Myung, et al.
Publicado: (2013)

Efficacy of a Dexamethasone-Eluting Nitinol Stent on the Inhibition of Pseudointimal Hyperplasia in a Transjugular Intrahepatic Portosystemic Shunt: An Experimental Study in a Swine Model
por: Seo, Tae-Seok, et al.
Publicado: (2005)

Long-Term Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Stents in Patients With Acute Myocardial Infarction: Four-Year Observational Study
por: Min, Gye-Sik, et al.
Publicado: (2012)

Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium
por: Jeon, Ki-Hyun, et al.
Publicado: (2023)

Real-World Three-Year Clinical Outcomes of Biolimus-Eluting Stents versus Other Contemporary Drug-Eluting Stents in Patients with Acute Myocardial Infarction Patients: Data from the Korea Acute Myocardial Infarction Registry (KAMIR)
por: Park, Ji Young, et al.
Publicado: (2021)

Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017)

Gender differences of in-hospital outcomes in patients undergoing percutaneous coronary intervention in the drug-eluting stent era
por: Kim, Hack-Lyoung, et al.
Publicado: (2019)

Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial
por: Park, Sang-Don, et al.
Publicado: (2013)

Bifurcation strategies using second-generation drug-eluting stents on clinical outcomes in diabetic patients
por: Cha, Jung-Joon, et al.
Publicado: (2022)

Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice
por: Lee, Joo Myung, et al.
Publicado: (2023)

Rupture and Spontaneous Sealing of a Coronary Aneurysm After Deployment of Drug-Eluting Stent
por: Kwon, Tae Jung, et al.
Publicado: (2012)

Erratum to: Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial
por: Park, Sang-Don, et al.
Publicado: (2017)

Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)

Sirolimus-eluting cobalt–chrome alloy stent suppresses stent-induced tissue hyperplasia in a porcine Eustachian tube model
por: Kang, Jeon Min, et al.
Publicado: (2022)

SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era
por: Kang, Jeehoon, et al.
Publicado: (2019)

Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated with Clinical Outcome after PCI
por: Park, Kyung Woo, et al.
Publicado: (2013)

Incremental age-related one-year MACCE after acute myocardial infarction in the drug-eluting stent era (from KAMIR-NIH registry)
por: Kim, Dae-Won, et al.
Publicado: (2018)

Impact of body fat distribution on long-term clinical outcomes after drug-eluting stent implantation
por: Park, Se-Jun, et al.
Publicado: (2018)

Association of Side-Branch Treatment and Patient Factors in Left Anterior Descending Artery True Bifurcation Lesions: Analysis from the GRAND-DES Pooled Registry
por: Oh, Gyu Chul, et al.
Publicado: (2020)

Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
por: Her, Ae-Young, et al.
Publicado: (2023)

Additive Value of B-Type Natriuretic Peptide on Rest (201)Tl-Dipyridamole Stress (99m)Tc-Sestamibi Gated Myocardial SPECT in Patients with Normal Left Ventricular Systolic Function
por: Sir, Jung-Ju, et al.
Publicado: (2010)

Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease
por: Park, Keun-Ho, et al.
Publicado: (2019)

Comparison of Two Different Strategies of Intravascular Ultrasound Guidance during Percutaneous Coronary Intervention; Routine versus Selective
por: Seo, Jae-Bin, et al.
Publicado: (2013)

Sex Differences in Midterm Prognostic Implications of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug‐Eluting Stents in East Asian Patients: Results From the PTRG‐DES (Platelet Function and Genotype‐Related Long‐Term Prognosis in Drug‐Eluting Stent–Treated Patients With Coronary Artery Disease) Consortium
por: Kim, Soo‐Jin, et al.
Publicado: (2023)

Efficacies of the new Paclitaxel-eluting Coroflex Please™ Stent in percutaneous coronary intervention; comparison of efficacy between Coroflex Please™ and Taxus™ (ECO-PLEASANT) trial: study rationale and design
por: Seo, Jae-Bin, et al.
Publicado: (2009)

Comparison of Different Types of Drug-Eluting Stents for De Novo Long Coronary Artery Lesions
por: Kang, Do-Yoon, et al.
Publicado: (2022)

Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5vjbuv01ms51betr877v8aec1t